The short version
Expandi is a mature, self-serve LinkedIn automation tool whose safety story is infrastructure: cloud-based sending, a dedicated country-based IP per account, gradual auto warm-up and algorithmic daily limits. Nova's safety story is architecture: an action ledger recording everything each account does, a governor that checks every single action against per-account budgets and trust-tier ramps, and a human approval queue in front of everything AI writes. Expandi makes automated sequences look like they come from a normal connection. Nova constrains the whole system so each account behaves like a person — and it adds Lead Radar discovery, deep lead research and a content studio that Expandi doesn't attempt.
What Expandi does well
Credit where due: Expandi takes safety seriously by category standards — dedicated country-based IPs and gradual warm-up were differentiators it pushed before most competitors talked about safety at all. Its sequence builder supports conditional if/then logic, it does multichannel steps (connection requests, messages, email), offers image/GIF and video personalisation add-ons, and its positioning explicitly favours research-backed limits over promised volume — a stance we respect. It is self-serve with a 7-day full trial, at $99/mo per account ($79/mo billed annually) with agency pricing for 10+ seats (as listed in July 2026).
Side by side
| Dimension | Nova | Expandi |
|---|---|---|
| Built for | Founders, sales teams, agencies wanting one system | Growth marketers, agencies running LinkedIn sequences |
| Pricing (listed July 2026) | Growth $49/mo per sender · Agency $749/mo per workspace (launch pricing) | $99/mo per account ($79/mo annual) · agency pricing 10+ seats |
| Safety approach | Action ledger + governor; per-account budgets and trust-tier ramps; engagement-only days for new accounts | Cloud platform, dedicated country-based IP, auto warm-up, smart daily limits |
| Warm-up of leads | Each lead is engaged (view, react) days before its invite | Profile auto warm-up ramps the account's activity volume |
| Lead discovery | Lead Radar: autonomous daily ICP-scored discovery, human-approved before contact | Imports from LinkedIn/Sales Navigator searches and engagement scraping |
| Per-lead research | Deep research feeds every first-message draft | Personalisation via placeholders + image/video add-ons |
| AI messaging | Drafts from research; human approval queue — nothing auto-sends | Sequences send automatically once launched; conditional logic controls flow |
| Channels | LinkedIn (incl. voice notes) and email — email as its own campaign, or as the day-7 move on a quiet invite | LinkedIn + email steps |
| Beyond outreach | Content studio, profile review, unified inbox | Campaign analytics, integrations |
| Access | Self-serve, 7-day free trial (no card); 14-day money-back | Self-serve, 7-day free trial |
Two meanings of "warm-up"
Worth being precise, because both products use the word. Expandi's warm-up ramps your account's activity volume gradually — real and useful. Nova's governor does that too, with trust tiers and an engagement-only first week for new accounts. Nova then adds the other warm-up: each lead sees engagement from you days before the invite arrives, so acceptance rates rise. Higher acceptance feeds back into account safety, because accepted invites are the trust signal LinkedIn reads. Infrastructure hides automation; behaviour-shaping reduces the thing detection looks for. We think you eventually need the second.
Choose Expandi if
- You want a tool with years of track record behind it — Nova is newer.
- You want one sequence that interleaves LinkedIn and email at the same person; in Nova a campaign runs one channel, and email only follows LinkedIn after an invite goes unanswered.
- You like building conditional if/then sequence logic yourself and don't want AI drafting or an approval workflow.
Choose Nova if
- You want safety enforced as architecture — every action checked against a ledger — rather than configured as limits you could set wrong.
- You want the funnel before the sequence handled too: discovery, ICP scoring, research and per-lead warm-up.
- You want a human approving every AI-drafted send, and content + inbox in the same system spending the same account budget.
See how we document the safety layer on the safety section and what our numbers count — then Start free trial if it fits.
Frequently asked questions
Is Nova safer than Expandi?
Honestly: nobody can prove a comparative ban-rate claim, including us, and you should distrust any tool that quotes one without publishing its methodology. What can be compared is mechanism. Expandi's safety story is infrastructure — cloud sending, a dedicated country-based IP per account, gradual auto warm-up and algorithmic daily limits, which make automated sequences look like normal connections. Nova's is architecture — an action ledger recording everything each account does, a governor checking every single action against per-account budgets and trust-tier ramps, human approval in front of everything AI writes, and per-lead engagement before each invite. Both are serious approaches; they defend against different detection surfaces. Our view, argued in the page above, is that behaviour-shaping eventually matters more than infrastructure — but that is our view, disclosed as such. Whichever way you lean, test the claim identically: ask each vendor what specifically happens at the moment a daily limit is hit.
Does Nova have a free trial like Expandi?
Yes — Nova is self-serve with a 7-day free trial and no card required, which matches Expandi's trial length and full-feature access (as listed in July 2026). One caveat worth setting expectations on, and it applies to any safety-first tool: a warm-up ramp means a new account spends its first days on engagement, not invites, so a week of trial shows you the product and the pipeline being built rather than a finished set of replies. Plan the trial around evaluating the system — ICP quality, research depth, the drafts in your approval queue — not around counting meetings booked. The first payment also carries a 14-day money-back guarantee, so the decision after the trial stays reversible.
Related comparisons
- Nova vs HeyReach — multi-sender scale vs depth per account
- Nova vs Dripify — simple drip sequencer vs the full system
- Nova vs Valley — signal-based AI SDR vs approval-first system
- Best LinkedIn outreach tools 2026 — all 8 tools ranked by account safety, verified pricing
- All comparisons · The account safety guide behind this page's argument
Expandi is a trademark of its respective owner. Nova is not affiliated with, sponsored by, or endorsed by Expandi. All third-party information on this page comes from publicly available sources — primarily expandi.io — as of the verification date shown above, and may have changed since. If you represent Expandi and believe anything here is inaccurate or outdated, email hello@joinnova.ai and we will review and correct it promptly.